News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38 Results
Type
Article (2)
Company Profile (1)
Press Release (35)
Section
Business (3)
Deals (1)
Drug Development (7)
FDA (1)
News (9)
Tag
Alliances (2)
Approvals (1)
Cell therapy (1)
Clinical research (8)
C-suite (1)
Data (2)
Events (20)
FDA (1)
IPO (1)
Manufacturing (1)
NextGen: Class of 2025 (1)
Non-profit (2)
People (2)
Pharmaceutical (1)
Phase I (3)
Phase II (3)
Phase III (4)
Date
Last 30 days (1)
Last 365 days (9)
2025 (5)
2024 (9)
2023 (4)
2022 (8)
2021 (4)
2020 (8)
Location
California (9)
Northern California (6)
United States (9)
38 Results for "orcabio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Orca Bio Appoints Key Executives Including Steve Gavel as Chief Commercial Officer
June 5, 2025
·
3 min read
Press Releases
Orca Bio Announces Leadership Updates - May 12, 2025
May 13, 2025
·
4 min read
Press Releases
Orca Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 7, 2025
·
1 min read
Press Releases
Orca Bio’s Orca-T® Meets Primary Endpoint in the Pivotal Precision-T Phase 3 Clinical Study for Hematologic Malignancies
February 10, 2025
·
4 min read
Press Releases
Orca Bio Announces Positive Results from the Pivotal Phase 3 Study of Investigational Orca-T® Compared to Allogeneic Stem Cell Transplant for the Treatment of Hematologic Malignancies
March 17, 2025
·
6 min read
Orca Bio
Press Releases
Orca Bio Presents Clinical Results on Use of Orca-Q® without GvHD Prophylaxis in Patients with Hematological Malignancies at the 66th ASH Annual Meeting
December 9, 2024
·
3 min read
Press Releases
Orca Bio Presents Three-Year Survival Data with Orca-T® in Patients with Hematological Malignancies at the 66th ASH Annual Meeting
December 9, 2024
·
6 min read
Press Releases
Orca Bio to Present Clinical Data on Its High-Precision Cell Therapies at the 66th American Society of Hematology Annual Meeting
November 5, 2024
·
4 min read
Drug Development
Orca Bio Announces Completion of Patient Enrollment for the Precision-T Phase 3 Study of Orca-T
Orca Bio today announced that it has completed enrollment in the pivotal Precision-T Phase 3 clinical study.
June 5, 2024
·
3 min read
1 of 4
Next
